GlassScriptPhysician profile
Jill S Miller
NPI 1023070612
$2,648.00
in general payments reported to CMS, 2019-2025
33 companies · $458 in 2025
The $458 reported for 2025 was more than what 84% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $492 · 2022: $419 · 2023: $843 · 2024: $436 · 2025: $458.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,638 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,638.09 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $545.80 | 2021-2025 | |
| Astellas Pharma US INC | $289.81 | 2023-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $288.13 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $249.55 | 2023-2024 | Myfembree |
| Pfizer INC. | $156.47 | 2022-2023 | |
| Hologic Sales and Service, LLC | $136.73 | 2023-2024 | Thinprep 2000 Processor, Aptima, Fluent Fluid Management System |
| Daiichi Sankyo INC. | $101.10 | 2021-2023 | Injectafer |
| Becton, Dickinson and Company | $83.37 | 2022-2025 | Bd Onclarity, Bd Veritor Plus Analyzer |
| Exact Sciences Corporation | $83.34 | 2023-2024 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $81.64 | 2021-2025 | |
| Evofem Biosciences, INC. | $78.74 | 2021 | |
| Exeltis, USA INC. | $62.08 | 2023-2024 | Slynd |
| Amgen INC. | $51.62 | 2021-2022 | |
| Myovant Sciences INC. | $47.00 | 2021-2022 | |
| Renovia INC | $43.98 | 2021 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $42.64 | 2025 | Wegovy |
| Avion Pharmaceuticals | $27.30 | 2021-2023 | Balcoltra |
| Axonics, INC. | $26.19 | 2023 | Axonics |
| Millicent US INC | $23.23 | 2025 | Femlyv |
| Supernus Pharmaceuticals, INC. | $21.05 | 2025 | Qelbree |
| Sage Therapeutics, LLC | $21.05 | 2025 | Zurzuvae |
| Pacira Pharmaceuticals Incorporated | $20.24 | 2022 | |
| Mycovia Pharmaceuticals, INC. | $17.76 | 2023 | Vivjoa |
| Merck Sharp & Dohme LLC | $16.74 | 2021 | |
| Kci USA, INC. | $15.99 | 2021 | |
| Organon LLC | $15.90 | 2022 | |
| Ascend Therapeutics US, LLC | $15.64 | 2024 | |
| Medtronic, INC. | $15.31 | 2023 | Ligasure |
| Gynesonics, INC. | $14.74 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Agile Therapeutics, INC. | $14.70 | 2022 | |
| Therapeuticsmd, INC. | $14.51 | 2022 | |
| Shield Therapeutics INC | $14.16 | 2023 | Accrufer |
| Amag Pharmaceuticals, INC. | $11.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jill Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.